Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin US4781601046
Ticker JNJ
Company JOHNSON & JOHNSON
Currency $
Price
Aware Investor Index (AII) 5.5705
Recommendation BUY
P/E 32.12
ROE 20.30 %
Capitalization 392,248,464,000 $
Dividend Yield 2.32 %
P/S 5.13
AII Position 111
P/E Position 425
ROE Position 150
Capitalization Position 11
Dividend Yield Position 287
Sales 76,450,000,000 $
10-Year Average Earnings 12,213,800,000 $
Shares Outstanding 2,745,300,000
Equity 60,160,000,000 $
Dividend per Share 3.32 $
Industry Personal Care
Country United States
JOHNSON & JOHNSON Investor Relations Web Site http://www.investor.jnj.com/investor-relations.cfm







Sales:

YEAR MONTH AMOUNT
2017 12 76,450,000,000.00 $
2016 12 71,890,000,000.00 $
2015 12 70,074,000,000.00 $
2014 12 74,331,000,000.00 $
2013 12 71,312,000,000.00 $

Earnings:

YEAR MONTH AMOUNT
2017 12 1,300,000,000.00 $
2016 12 16,540,000,000.00 $
2015 12 15,409,000,000.00 $
2014 12 16,323,000,000.00 $
2013 12 13,831,000,000.00 $
2012 12 10,514,000,000.00 $
2011 12 9,672,000,000.00 $
2010 12 13,334,000,000.00 $
2009 12 12,266,000,000.00 $
2008 12 12,949,000,000.00 $

Equity:

YEAR MONTH AMOUNT
2017 12 60,160,000,000.00 $
2016 12 70,418,000,000.00 $
2015 12 71,150,000,000.00 $
2014 12 69,752,000,000.00 $
2013 12 74,053,000,000.00 $
2012 12 64,826,000,000.00 $
2011 12 57,080,000,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2017 12 2,745,300,000
2016 12 2,788,900,000
2015 12 2,812,900,000
2014 12 2,863,900,000
2013 12 2,877,000,000
2012 12 2,812,600,000
2011 12 2,775,300,000

 












Bloomberg News for JOHNSON & JOHNSON:



Google News for JOHNSON & JOHNSON:

Yahoo Finance - 4 days ago
Why Johnson & Johnson (JNJ) Could Beat Earnings Estimates Again
It is worth considering Johnson & Johnson (JNJ), which belongs to the Zacks Large Cap Pharmaceuticals industry. This world's biggest maker ...
NMSU Nеws - 19 hours ago
Buy And Hold, And Diversify: Zoetis Inc. (ZTS), Johnson & Johnson ...
Taking a look at the current stock price for Johnson & Johnson (NYSE:JNJ), we could notice that the shares are trading close to the $140.46 ...
Baseball Daily News
Dividend Champion Spotlight: Johnson & Johnson
Johnson & Johnson (JNJ) is a titan of the industry, and one of the most well known companies among dividend growth investors. Carrying a ...
Marea Informative (blog)
Johnson & Johnson (JNJ) Management Presents at Barclays Global ...
Johnson & Johnson (NYSE:JNJ) Barclays Global Consumer Staples Conference Call September 6, 2018 12:45 PM ET. Executives.
Equities.com
Johnson & Johnson (JNJ) Not Finding Court Actions Favorable In ...
Johnson & Johnson (NYSE:JNJ) has been running into trouble in the court room, and the company is simply not having success with the ...
Seeking Alpha - 2 Sep 2018
Johnson & Johnson (JNJ) Pharmaceutical Business Review ...
Johnson & Johnson (NYSE:JNJ) Pharmaceutical Business Review Conference Call September 13, 2018 10:00 AM ET. Executives.
Marea Informative (blog)
There Is A More Important Question Than High P/E Ratios Affecting ...
I disagree with the implied assumption in the article that a "high" P/E ratio for Johnson & Johnson (NYSE:JNJ) translates to overvalued and a ...
PressOracle
Boston Scientific, Edwards Lifesciences May Tempt J&J
While conceding that Johnson & Johnson hasn't commented on Edwards or Boston as an acquisition target, the Wells Fargo analyst wrote that ...
Baseball Daily Digest
Johnson & Johnson: Where Is The Path To Gains?
Johnson & Johnson (JNJ) has trended higher since the stock hit its lows of $119.40 per share in the month of May. Despite strong earnings ...
Seeking Alpha - 6 Sep 2018
Brokerages Anticipate Johnson & Johnson (JNJ) Will Announce ...
Analysts expect that Johnson & Johnson (NYSE:JNJ) will report sales of $19.91 billion for the current fiscal quarter, according to Zacks.


Back